Too early to tell, but preliminary information from doctors in South Africa suggests the new Covid variant Omicron may be associated with less severe disease.
The Omicron Variant: What Matters Most Is… – by Dr David L. Katz New Covid Variant Omicron: South African medical association says Omicron variant causes ‘mild disease’ – Times of India Video: Omicron symptoms mild so far, says South African doctor who spotted it – BBC South African doctor who raised alarm about omicron variant […]
The post Too early to tell, but preliminary information from doctors in South Africa suggests the new Covid variant Omicron may be associated with less severe disease. appeared first on Links Medicus.
WHO Update on Omicron + Several Articles on the Subject.
Update on Omicron – World Health Organization Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern – World Health Organization See also: Omicron COVID-19 variant: Africa CDC statement Expert reaction to B.1.1.529 variant situation in South Africa; and UK travel restrictions in response – Science Media Centre Threat Assessment Brief: Implications of the emergence and spread […]
The post WHO Update on Omicron + Several Articles on the Subject. appeared first on Links Medicus.
Phase II RCT: Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma.
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma – New England Journal of Medicine (link to abstract – $ for full-text) Commentaries on Twitter Visual Abstract: Efficacy and Safety of Itepekimab for Moderate-to-Severe Asthma https://t.co/7mldcsSaeW pic.twitter.com/RlvE2Z1Tas — NEJM (@NEJM) November 3, 2021 In this randomized trial, the monoclonal antibody itepekimab against interleukin-33 […]
The post Phase II RCT: Efficacy and safety of Itepekimab in patients with moderate-to-severe asthma. appeared first on Links Medicus.
[Preprint] Serological responses to COVID-19 booster vaccine in England.
Serological responses to COVID-19 booster vaccine in England – medRxiv Commentary from the author on Twitter (thread – click for more) 1/ Our preprint on #SARSCoV2 antibody responses in UK adults receiving a #COVID19 vaccine booster with the Pfizer vaccine at least 6 months after primary immunisation with Pfizer or AZ vaccine, which was […]
The post [Preprint] Serological responses to COVID-19 booster vaccine in England. appeared first on Links Medicus.
M-A: Comparing the clinical efficacy of COVID-19 vaccines.
Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis – Scientific Reports
The post M-A: Comparing the clinical efficacy of COVID-19 vaccines. appeared first on Links Medicus.
Heavily mutated coronavirus variant puts scientists on alert – “Researchers are racing to determine whether a fast-spreading variant in South Africa poses a threat to COVID vaccines’ effectiveness”.
Heavily mutated coronavirus variant puts scientists on alert – Nature See also: Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern – BBC WHO calls special meeting to discuss new Covid variant found in South Africa with ‘a large number of mutations’ – CNBC New COVID-19 Variant With Multiple Concerning Mutations Identified in […]
The post Heavily mutated coronavirus variant puts scientists on alert – “Researchers are racing to determine whether a fast-spreading variant in South Africa poses a threat to COVID vaccines’ effectiveness”. appeared first on Links Medicus.
Review: Prevention and management of thrombosis in hospitalized patients with COVID-19 pneumonia.
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia – The Lancet Respiratory Medicine
The post Review: Prevention and management of thrombosis in hospitalized patients with COVID-19 pneumonia. appeared first on Links Medicus.
Systematic Review: Macrolides versus placebo for chronic asthma.
Macrolides versus placebo for chronic asthma – Cochrane Library Commentary on Twitter Graphical abstract for #Cochrane Review on #Macrolides versus placebo for chronic #asthma Full review here https://t.co/SrHacxWoNr pic.twitter.com/0YCd9Xptlz — CochraneAirways (@CochraneAirways) November 24, 2021
The post Systematic Review: Macrolides versus placebo for chronic asthma. appeared first on Links Medicus.
Promises and challenges of personalized medicine to guide ARDS therapy.
Promises and challenges of personalized medicine to guide ARDS therapy – Critical Care
The post Promises and challenges of personalized medicine to guide ARDS therapy. appeared first on Links Medicus.
COVID-19 reinfection: the role of natural immunity, vaccines, and variants.
COVID-19 reinfection: the role of natural immunity, vaccines, and variants – Journal of Community Hospital Internal Medicine Perspectives Related: [Preprint] M-A of 12.011.447 individuals finds individuals previously infected with SARS-CoV-2 had an 81% reduction in odds of a reinfection.
The post COVID-19 reinfection: the role of natural immunity, vaccines, and variants. appeared first on Links Medicus.